Vanguard Personalized Indexing Management LLC Purchases 13,165 Shares of Danaher Corporation $DHR

Vanguard Personalized Indexing Management LLC increased its position in Danaher Corporation (NYSE:DHR) by 23.7% in the second quarter, Holdings Channel.com reports. The fund owned 68,626 shares of the conglomerate’s stock after acquiring an additional 13,165 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Danaher were worth $13,559,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. GHP Investment Advisors Inc. boosted its position in shares of Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 99 shares during the period. Sierra Ocean LLC boosted its position in shares of Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 76 shares during the period. Red Tortoise LLC boosted its position in shares of Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after acquiring an additional 98 shares during the period. Smallwood Wealth Investment Management LLC bought a new position in shares of Danaher in the first quarter valued at approximately $31,000. Finally, Dunhill Financial LLC lifted its position in Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 67 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director Teri List sold 2,778 shares of the company’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 11.10% of the stock is owned by corporate insiders.

Danaher Trading Down 1.0%

Shares of DHR opened at $202.53 on Friday. The firm has a market cap of $145.02 billion, a price-to-earnings ratio of 43.09, a PEG ratio of 2.88 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.41. The firm has a 50 day moving average price of $200.66 and a 200-day moving average price of $197.16.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. During the same period in the prior year, the business posted $1.72 EPS. The firm’s revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio is currently 27.23%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on DHR. Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a research note on Wednesday. Scotiabank raised shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target for the company in a research note on Friday, July 11th. Bank of America cut their price target on shares of Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research note on Monday, September 22nd. Wells Fargo & Company cut their price target on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 23rd. Finally, Redburn Partners set a $220.00 price target on shares of Danaher in a research note on Wednesday. Seventeen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $244.60.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.